1,3-Propanesultam → 2-[4-[6-(1,1-Dioxo-1lambda6-isothiazolidin-2-yl)pyridine-3-carbonyl]piperazin-1-yl]-5-methylnicotinonitrile
反応式
Br[C:2]1[N:7]=[CH:6][C:5]([C:8]([N:10]2[CH2:15][CH2:14][N:13]([C:16]3[N:23]=[CH:22][C:21]([CH3:24])=[CH:20][C:17]=3[C:18]#[N:19])[CH2:12][CH2:11]2)=[O:9])=[CH:4][CH:3]=1.[S:25]1(=[O:31])(=[O:30])[CH2:29][CH2:28][CH2:27][NH:26]1>>[O:30]=[S:25]1(=[O:31])[CH2:29][CH2:28][CH2:27][N:26]1[C:2]1[N:7]=[CH:6][C:5]([C:8]([N:10]2[CH2:15][CH2:14][N:13]([C:16]3[N:23]=[CH:22][C:21]([CH3:24])=[CH:20][C:17]=3[C:18]#[N:19])[CH2:12][CH2:11]2)=[O:9])=[CH:4][CH:3]=1参加物
3
実験手順
Using 2-[4-(6-bromopyridine-3-carbonyl)piperazin-1-yl]-5-methylnicotinonitrile (150 mg) described in Preparation Example 184 and isothiazolidine 1,1-dioxide (71 mg) and by the reaction and treatment in the same manner as in Example 1, the title compound (114 mg) was obtained.
出典と根拠
- ORDレコード
- ord-d4b8ffd1c08543398996c89ba1dc4fc2
- 出典データセット